Jair Bar

Jair Bar, MD, PhD, Professor

Thoracic Oncologist | Deputy Director of Cancer Center | Lung Cancer Specialist

Areas of Expertise

Professor Jair Bar specializes in thoracic oncology, with a strong focus on advanced lung cancer treatment and translational research:

Lung Cancer (non-small cell and advanced stages)

Thoracic Oncology

Medical Oncology & Radiotherapy

Molecular Biology & Genetics in Cancer

Immunotherapy and Resistance Mechanisms

Translational Oncology Research

About the Doctor

Professor Jair Bar is a leading thoracic oncologist and serves as the Deputy Director of the Cancer Center at Sheba Medical Center.

He also heads the Thoracic Oncology Unit, where he focuses on the treatment of lung cancer using advanced systemic therapies, including immunotherapy and targeted treatments.

In addition to his clinical work, Prof. Bar leads a research laboratory dedicated to studying resistance to immunotherapy, contributing to the development of more effective cancer treatment strategies.

He combines clinical expertise with cutting-edge research, ensuring that patients benefit from the most up-to-date therapeutic approaches.

Clinical Approach

Personalized cancer treatment based on molecular and genetic profiling

Integration of immunotherapy, targeted therapy, and radiotherapy

Multidisciplinary decision-making for complex cases

Focus on improving survival outcomes and quality of life

Positions

Deputy Director, Cancer Center, Sheba Medical Center

Head of Thoracic Oncology Unit

Chair, Israel Lung Cancer Group (since 2003)

Senior Lecturer, Tel Aviv University

Professional Memberships

Member of Israel Society of Clinical Oncology and Radiotherapy

Member of American Society of Clinical Oncology

Member of American Association for Cancer Research

Education and Training

MD, Hebrew University of Jerusalem (Hadassah Medical School)

PhD in Molecular Biology, Weizmann Institute of Science

Board Certifications

Medical Oncology

Radiotherapy Oncology

Research & Publications

Professor Bar is actively involved in translational and clinical research, with publications focused on lung cancer biology and treatment, including:

Cancer metabolism in lung cancer based on exhaled breath analysis

Angiogenesis inhibition strategies in lung cancer therapy

He continues to contribute to advancing precision oncology and immunotherapy approaches in thoracic cancers.